EVGN

#4941
EVOGENE LTD.
0.82 USD
0.00%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
0.82
0.82
년간 변동
0.72
2.42
일일 변동
0.00%
월간 변동
-1.20%
6달 변화
-38.35%
년간 변동율
-21.90%
이전 종가
0.82
Open
0.82
Bid
Ask
Low
0.82
High
0.82
양
5
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 7.15 M
  • Employee 52
  • Founded 1999
  • CEO Ofer Haviv
  • Website www.evogene.com
  • Headquarter Israel
  • FIGI UNKNOWN
  • Industry Technology
총매출
Net income
Total debt
Free cash flow
Cash & equivalents

Evogene Ltd

Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs. In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture.

뉴스